Comparison of the effects of monotherapy with exenatide or metformin to combined exenatide and metformin therapy on menstrual cyclicity in overweight women with polycystic ovary syndrome

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 10 Nov 2021

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Exenatide (Primary) ; Metformin
Indications Obesity; Polycystic ovary syndrome; Type 2 diabetes mellitus
Focus Pharmacodynamics

Most Recent Events

07 Sep 2008 Results presented at the 44th Annual Meeting of the European Association for the Study of Diabetes.
11 Jul 2007 Status change from in progress to completed.
04 Nov 2006 New trial record.

Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

IP authentication when working within your organization’s network.
Login with username/password or try access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days.
Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

Contact your organization’s admin about adding this content to your AdisInsight subscription
Buy a PDF version of the profile.
Request a free trial

Welcome to AdisInsight